SOURCE: Telzuit Medical Technologies, Inc.

July 12, 2007 10:38 ET

Telzuit Medical Technologies: Update on Sales and Technology

ORLANDO, FL--(Marketwire - July 12, 2007) -

Telzuit Medical Technologies, Inc. (OTCBB: TZMT)

--  Manufacturing problems have caused delays in delivery and initiation
    of use of the patch.
--  On July 11, initial use of the patch began.
--  While production ramp up will remain slow, the Company is beginning
--  Use of new Palm technology has greatly increased the reliability of
    the product.
The initial production runs of the product resulted in problems with the on-switch of the STATPATCH. The Company has had to delay delivery on approximately 400 STATPACHs in June. We have resolved these problems and have restarted production of the patch. We have also begun testing of a new Palm Treo PDA utilizing Windows Mobile 6.0. This device enables us to complete a 24-hour holter monitor test without having to recharge the PDA. Additionally it will double the range of the Bluetooth module, greatly increasing the ease of use of the STATPATCH System.

Yesterday, July 11, we initiated use of the STATPATCH System on patients, creating billable events. We will begin roll-out of the product on a controlled basis and will accelerate the roll-out when PALM and AT&T release the new Windows Mobile 6.0 Palm Treo.

Warren Stowell, CEO of Telzuit, commented, "I am disappointed that we have had unforeseen production problems that delayed the general release of the product. However, it gave us more time to improve the product. I now believe we have the best solution for 24-hour holter monitor testing."

About Telzuit Medical Technologies, Inc.

Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine to patients. The STATPATCH System is a full 12-lead, completely wireless Holter monitor. The STATPATCH System has been approved by the FDA under a 510-K filing. Telzuit also provides ultrasound medical imaging services to physicians in Central Florida through six mobile imaging units. Telzuit is based in Orlando. For more information about Telzuit, its business model and its products, please visit the Company's web site:

Forward-Looking Statements: Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.

Contact Information

  • Contact:

    Jerry Balter
    Chief Financial Officer
    Telzuit Medical Technologies, Inc.